PSI/Papua New Guinea planned to introduce artemisinin-based combination therapies (ACT) to its product line to treat malaria, while promoting complementary malaria control strategies like long-lasting insecticide-treated nets (LLIN) and rapid diagnostic tests (RDT). This FoQus study determined barriers to LLIN and ACT use, including discomfort when using nets and greater trust in traditional treatment methods. PSI/PNG used this information to create effective messages to promote malaria control and treatment.
Related content by category
Country: Papua New Guinea, Asia / Pacific
Health Areas: Malaria
Type: Qualitative Research Sum. (FoQus)
FoQus Type: FoQus for Qualitative Segmentation
Behavior Type: Malaria Prevention